Aptose Biosciences Inc.

  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
  • Product Pipeline
    • Overview
    • Tuspetinib for AML
    • Luxeptinib for B-cell Tumors
    • Luxeptinib for Myeloid Tumors
    • Posters & Presentations
  • Clinical Trials
    • Overview
    • Luxeptinib for CLL & NHL
    • Luxeptinib for AML
    • Tuspetinib for AML
    • Expanded Access
  • News
    • Press Releases
    • Presentations
    • Events
  • Investors
    • Overview
    • News & Events
    • Company Info
    • Financial Info
    • Stock Data
    • SEC Filings
    • SEDAR
    • Governance
  • Join Us
    • Values & Culture
    • Perks & Benefits
    • Explore Careers
  • Contact

Press Releases

Investors

Investors

  • Overview
  • News & Events
    • Overview
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Info
    • Overview
    • Management Team
    • Presentations
    • Contacts
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Cash Flow
  • Stock Data
    • TSX: APS
    • Analyst Coverage
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • SEDAR
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
  • News & Events

  • Overview
  • Press Releases
  • IR Calendar
  • Email Alerts

Aptose Biosciences and CrystalGenomics Announce Issuance of European Patent for CG-806

Sep 27, 2018 7:05am EDT

Aptose to Present at Upcoming Investor Conferences in October 2018

Sep 25, 2018 7:05am EDT

Aptose to Present at Upcoming Investor Conferences in September 2018

Aug 29, 2018 7:05am EDT

Aptose Announces Appointment of Carol Ashe to Board of Directors

Aug 15, 2018 7:05am EDT

Aptose Reports Results for the Second Quarter Ended June 30, 2018

Aug 07, 2018 4:18pm EDT

Aptose Biosciences to Present at Canaccord Genuity 38th Annual Growth Conference

Aug 02, 2018 7:05am EDT

Aptose to Present at the 2018 Global Congress on Oncology and Cancer

Jul 31, 2018 8:00am EDT

Aptose To Release Second Quarter Ended June 30, 2018 Financial Results and Hold Conference Call on August 7, 2018

Jul 24, 2018 7:05am EDT

Aptose Biosciences and CrystalGenomics Announce Issuance of Japanese Patent for CG-806

Jul 10, 2018 7:00am EDT

Aptose Biosciences to Participate at the Oppenheimer & Co. Inc. Boston Oncology Insight Summit and 1x1 Day

Jul 09, 2018 7:00am EDT
RSS
  • Prev
    • 1...
    • 16
    • 17
    • 18
    • 19
    • 20
    • 21
    • 22
    • 23
    • 24
    • 25
    • ...32
    Next
    • Email Alerts
    • Contacts
    • RSS News Feed
    © 2025 Aptose Biosciences Inc. All Rights Reserved.
    Privacy Policy Clinical Trials Policy Disclaimer Sitemap Manage Cookie Preferences